• 20 September, 2026
According to GBI Research, the growth will primarily be driven by the emergence of novel therapeutics

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...

January 19, 2017 | Thursday | News

Podcast

Most Read

Survey Box

Is Asia Pacific region racing towards greener & sustainable pharma?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls